Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1991-05-08
1992-02-18
Shen, Cecilia
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514 80, 514 81, 544244, 544277, A61K 3152, C07D47330, C07D47332
Patent
active
050895001
ABSTRACT:
The present invention relates to 6-substituted purine carbocyclic nucleosides and their use in medical therapy particularly in the treatment of HIV and HBV infections. Also provided are pharmceutical formulations and processes for the preparation of compounds according to the invention.
REFERENCES:
patent: 4605659 (1986-08-01), Verheyden et al.
patent: 4931559 (1990-06-01), Vince et al.
patent: 4950758 (1990-08-01), Vince et al.
patent: 4954504 (1990-09-01), Chen et al.
patent: 4968674 (1990-11-01), Taniyama et al.
Yoshikawa, et al., Bulletin Chem. Soc., Japan, vol. 42, No. 12, 1969, pp. 3505-3508, Studies of Phosphorylation, III. Selective Phosphorylation of Unprotected Nucleosides.
Hoard, et al., J. Amer. Chem. Soc., vol. 87, No. 8, Apr. 20, 1965, pp. 1785-1788, Conversion of Mono- and Oligodeoxyribonucleotides of 5'-Triphosphates.
Shuto et al., Chem. Pharm. Bulletin, vol. 36, No. 12, 1988, pp. 5020-5023 Phospholipase D-Catalyzed Trans-Alkylphosphorylation: A Facile One-Step Synthesis of Nucleoside 5'-Alkylphosphates.
Shuto et al., Tetrahedron Letters, vol. 28, No. 2, 1987, p. 199-202, A Facile One-Step Synthesis of 5'-Phosphatidylnucleosides by an Enzymatic Two-Phase Reaction.
Bosowsky et al., Nucleic Acid Chemistry, Part 3, Editors: L. B. Townsend & R. S. Tipson, 1986, pp. 255-258, Alkyl Esters of 9-(5-O-Phosphone-.beta.-D-Arabinofuranosyl)-Adenine.
Davoll et al., J. Chem. Soc., 1960, pp. 5041-5049, The Synthesis of 9-Glycitylpurines, 3-Glycityl-[1,2,3]-triazolo[d]-pyrimidines, 8-Glycitylpteridines, and 10-Glycitylbenzo[g]pteridines, including and Riboflavin and Riboflavin 2-Imine.
Bencini et al., Analytical Biochemistry, vol. 132, 1983, pp. 254-258 Linear One-Step Assay for the Determination of Orthophosphate.
Sells et al., Proc. Natl. Acad. Sci. U.S.A., vol. 84, Feb. 1987, pp. 1005-1009, Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA.
E. M. Southern, J. Mol. Biol., vol. 98, 1975, pp. 503-517, Detection of Specific Sequences Among DNA Fragments Separated by Gel Electrophoresis.
Antiviral Research, vol. 9, No. 1/2, Jan./Feb., 1988, ISSN 0166-3542, Elsevier.
Daluge et al., J. Org. Chem., vol. 43, No. 12, 1978, pp. 2311-2320, Synthesis of Carbocyclic Aminonucleosides.
Yeom et al., Antimicrob. Agents Chemotherapy, Feb., 1989, vol. 33, No. 2, pp. 171-175, Pharmacokinetics and Bioavailability of Carbovir, a Carbocyclic Nucleosede Active against Human Immuodeficiency Virus, in Rats.
Vince et al., Biochemical and Biophysical Research Communications, vol. 156, No. 2, Oct. 31, 1988, pp. 1046-1053, Potent and Selective Activity of a New Carbocyclic Nucleoside Analog (Carbovir: NSC 614846) Against Human Immunodeficiency Virus in vitro.
Marquez et al., Nucleosides and Nucleotides, 6(1&2), pp. 239-244 (1987) Synthesis of 2',3'-Dideoxycyclopentenyl Carbocyclic Nucleosides as Potential Drugs for the Treatment of Aids.
Remmel et al., Journal of Chromatography, 489, (1989), pp. 323-331, Liquid Chromatographic Assay of Carbovir, A carbocyclic Nucleoside Active Against Human Immunodeficiency Virus.
Abstract No. 802, MINU, Synergistic Antiviral Combination.
White et al., Biochemical and Biophysical Research, vol. 161, No. 2, Jun. 15, 1989, pp. 393-398, Comparison of the Effect of Carbovir, AZT, and Dideoxynucleoside Triphosphates on the Activity of Human Immunodeficiency Virus Reverse Transcriptase and Selected Human Polymerases.
Chemical Abstracts, vol. 108, No. 21, May 23, 1988.
Chemical Abstracts, vol. 110, No. 7, Feb. 13, 1989.
Chemical Abstracts, vol. 111, No. 5, Jul. 31, 1989.
Brown Donald
Burroughs Wellcome Co.
Green Hannah O.
Nielsen Lawrence A.
Shen Cecilia
LandOfFree
Therapeutic nucleosides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Therapeutic nucleosides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic nucleosides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1823807